Vitamin D Deficiency Increases Severity of Paclitaxel-Induced Peripheral Neuropathy

PURPOSE: Approximately 25% of patients receiving weekly paclitaxel for breast cancer require treatment disruptions to avoid severe, irreversible peripheral neuropathy (PN). Vitamin insufficiencies are PN risk factors in many diseases, but their relevance to chemotherapy-induced PN is unknown. METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Jennaro, Theodore, Fang, Fang, Kidwell, Kelley M, Lavoie Smith, Ellen M., Vangipuram, Kiran, Burness, Monika L, Griggs, Jennifer J., Van Poznak, Catherine, Hayes, Daniel F., Henry, N. Lynn, Hertz, Daniel L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7945004/
https://ncbi.nlm.nih.gov/pubmed/32166478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05584-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados